Research map: Survivorship Challenges in Metastatic Prostate Cancer in the Era of Prolonged Survival: A Review

Back to the article

Papers in this map

  1. Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer · Chris C. Parker · 2013 · 3413 citations · Cited by this paper
  2. NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026 · 2026 · Related
  3. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes · A. Michael Lincoff · 2023 · 3058 citations · Cited by this paper
  4. Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control · 2026 · Related
  5. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer · Christopher J. Sweeney · 2015 · 2922 citations · Cited by this paper
  6. Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study · 2026 · Related
  7. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer · Oliver A. Sartor · 2021 · 2844 citations · Cited by this paper
  8. Mapping Misconceptions in Neuroendocrine Tumor Nomenclature: A Scoping Review of National Database Studies and Clinical Implications · 2026 · Related
  9. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer · Karim S. Fizazi · 2017 · 2313 citations · Cited by this paper
  10. Interpreting Circulating Bile Acid Profiles in Pancreatic Cancer: The Role of Cholestasis and Its Management · 2026 · Related
  11. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes · Juan P. Frías · 2021 · 2036 citations · Cited by this paper
  12. Ex Vivo Line-Field Confocal Optical Coherence Tomography and Ex Vivo Fusion Confocal Microscopy for Lateral-Margin Assessment of Basal Cell Carcinoma in Correlation with Histopathology: A Prospective Pilot Diagnostic-Accuracy Study · 2026 · Related
  13. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial · Nicholas David James · 2015 · 1986 citations · Cited by this paper
  14. Burden, Trends, and Future Projections of Multiple Myeloma in China from 1990 to 2023 · 2026 · Related
  15. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study · Karim S. Fizazi · 2011 · 1979 citations · Cited by this paper
  16. PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy · 2026 · Related
  17. Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer · Ian D. Davis · 2019 · 1651 citations · Cited by this paper
  18. Predictive Biomarkers of Systemic Therapy Response in Cutaneous Melanoma · 2026 · Related
  19. Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer · Kim N. Chi · 2019 · 1577 citations · Cited by this paper
  20. Incretin Mimetics in Cancer and Cardiovascular Disease · 2026 · Related
  21. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial · Piet Ost · 2017 · 1376 citations · Cited by this paper
  22. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial · Christopher Parker · 2018 · 1288 citations · Cited by this paper
  23. ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer · Andrew J. Armstrong · 2019 · 1241 citations · Cited by this paper
  24. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer · Ryan Phillips · 2020 · 1179 citations · Cited by this paper
  25. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial · Christos E. Kyriakopoulos · 2018 · 1128 citations · Cited by this paper
  26. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer · Matthew R. Smith · 2022 · 972 citations · Cited by this paper
  27. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial · Karim S. Fizazi · 2019 · 841 citations · Cited by this paper
  28. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design · Karim S. Fizazi · 2022 · 828 citations · Cited by this paper
  29. Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer · Ronald de Wit · 2019 · 685 citations · Cited by this paper
  30. Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer · Nancy L. Keating · 2009 · 629 citations · Cited by this paper
  31. Intermittent versus Continuous Androgen Deprivation in Prostate Cancer · Maha Hussain · 2013 · 583 citations · Cited by this paper
  32. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity · Louis J. Aronne · 2025 · 572 citations · Cited by this paper
  33. Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial · Neeraj Agarwal · 2023 · 535 citations · Cited by this paper
  34. Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study · Kim N. Chi · 2021 · 530 citations · Cited by this paper
  35. Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial · Gaëlle Vanbutsele · 2018 · 491 citations · Cited by this paper
  36. Rucaparib or Physician’s Choice in Metastatic Prostate Cancer · Karim S. Fizazi · 2023 · 450 citations · Cited by this paper
  37. Tirzepatide for Obesity Treatment and Diabetes Prevention · Ania M. Jastreboff · 2024 · 441 citations · Cited by this paper
  38. Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer · Paul Linh Nguyen · 2011 · 437 citations · Cited by this paper
  39. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial · Filip Krag Knop · 2023 · 417 citations · Cited by this paper

Source: OpenAlex (CC0)